Trial intelligence / Profile preview

Exenatide Mechanisms of Weight Loss in Obesity

NCT01590433Phase 4Completed

Start
Mar 2012
Primary completion
Jan 2019
Modality
Peptides
Countries
1
01

Overview

A Phase 4 trial of exenatide in obesity. Started Mar 2012; status: completed.

02

Drugs

exenatide
03

Conditions

obesity

Beyond the preview

Go deeper on NCT01590433.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01590433.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call